Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SeroCOVIDial: SARS-COV2 Seroconversion in Hemodialysis Patients
NCT04420338Unknown
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Jun 2020
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Trial (2 arms), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Prevalence of SARS-COV2 seroconversion in chronic hemodialysis patients at 6 months. Status: unknown.
Beyond the preview
Go deeper on NCT04420338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04420338.